Stay updated with breaking news from Achromatopsia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Natasha Caudill is a social media influencer and accessibility advocate debugging the monochrome world for you. She speaks to Interesting Engineering about her life experiences, social media interactions, advocacy, and being a part of NASA's unveiling of the first images from the James Webb Space Telescope.
(3) LONDON (dpa-AFX) - Today's Daily Dose brings you news about Applied Genetic's Achromatopsia trial results; the deadlock in AstraZeneca vaccine supply in EU; partnership of Lilly, Vir Biotech and GlaxoSmithKline in fighting COVID-19; and ZymeWork's progress with ZW49 study. Read on. 1. Applied Genetic Throws Light on Achromatopsia Trials Applied Genetic Technologies Corp.'s (AGTC) phase I/II clinical trials evaluating AAV gene therapy product candidates in patients with achromatopsia caused by CNGB3 or CNGA3 mutations, dubbed ACHMB3 and ACHMA3 trials, have provided for the first time quan...